FORT WORTH, Texas, June 15, 2011 /PRNewswire/ -- Wound Management Technologies, Inc., (OTCQB: WNDM | WNDM.PK) a leader in advanced wound care solutions, today announced that its direct-to-consumer television sales program for CellerateRX® has entered rotation within the programming of the Fox News Channel. Fox News, home of such shows as The O'Reilly Factor, Hannity's America, and Geraldo at Large, will run the commercial spots throughout the programming day.
The CellerateRX commercial was produced by TV Goods, Inc and is being distributed by MED3TV, LLC. The spot contains a demonstration of how the FDA-cleared collagen based product works, while providing a medical validation of the product from Dr. Peter Demitry, specialty trained in Occupational and Environmental Medicine, Harvard University and Fellow of the Aerospace Medical Association.
Kevin Harrington, Celebrity Judge on the ABC TV show Shark Tank and Chairman of H&H Imports Inc, the parent company of TV Goods, states, "The CellerateRX story has mass appeal and needs to be heard by the largest audience possible. The Fox News Network, America's highest rated non-entertainment network, is a perfect fit for this product to reach its target audience."
According to Deborah Jenkins Hutchinson, President of Wound Management Technologies, "Peter Lynch, the legendary former manager of the Fidelity Magellan Fund, popularized the investment philosophy of 'investing in what you know'. The Fox News placements should bring our brand and product awareness to new levels, as more and more consumers discover the benefits of CellerateRX. We are anticipating and will welcome the increased investor inquiries and interest that these spots will generate."
About Wound Management Technologies, Inc.
Wound Management Technologies, Inc. is an emerging commercial stage company with its primary products in the $5B worldwide advanced
|SOURCE Wound Management Technologies, Inc.|
Copyright©2010 PR Newswire.
All rights reserved